Related Experiment Video
Updated: Jun 11, 2026

06:07
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Murine complement deficiency ameliorates acute cigarette smoke-induced nasal damage
Kara S Davis1, Sarah E Casey, Jennifer K Mulligan
1Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, SC 29425, USA.
Summary
Cigarette smoke exposure activates the complement system, leading to nasal mucosal damage. Complement deficiency significantly reduced this damage in animal models, suggesting a protective role.
Area of Science:
- Immunology
- Otorhinolaryngology
- Toxicology
Background:
- Cigarette smoke is a known risk factor for chronic rhinosinusitis.
- Complement fragments are activated in human nasal mucosa, but the mechanisms are unclear.
Purpose of the Study:
- To investigate the effects of cigarette smoke on nasal mucosa.
- To determine the role of the complement system in smoke-induced nasal damage.
Main Methods:
- In vitro exposure of human respiratory epithelial cells to cigarette smoke extract (CSE) with human serum.
- In vivo exposure of complement-deficient (C3(-/-), factor B(-/-)) and wild-type mice to cigarette smoke.
- Assessment of complement activation via ELISA and immunofluorescence.
- Histological analysis of nasal cavity damage.
Main Results:
- CSE exposure activated the complement system in vitro, with C3d deposition observed.
- Complement deficiency (C3 or factor B) significantly reduced smoke-induced histological damage in mice compared to wild-type controls.
Conclusions:
- Cigarette smoke activates the complement system in the nasal mucosa.
- Complement deficiency confers protection against cigarette smoke-induced mucosal damage.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation

